Omeprazole and Normochromic normocytic anaemia - a phase IV clinical study of FDA data
Normochromic normocytic anaemia is found among people who take Omeprazole, especially for people who are male, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Omeprazole and have Normochromic normocytic anaemia. It is created by eHealthMe based on reports of 351,142 people who have side effects when taking Omeprazole from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
351,142 people reported to have side effects when taking Omeprazole.
Among them, 177 people (0.05%) have Normochromic normocytic anaemia.
What is Omeprazole?
Omeprazole has active ingredients of omeprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 359,875 Omeprazole users for its effectiveness, alternative drugs and more.
What is Normochromic normocytic anaemia?
Normochromic normocytic anaemia (forms of anaemia in which the average size and haemoglobin content of the red blood cells are within normal limits) is found to be associated with 1,068 drugs and 604 conditions by eHealthMe.
Number of Omeprazole and Normochromic normocytic anaemia reports submitted per year:
Time on Omeprazole when people have Normochromic normocytic anaemia *:
Gender of people who have Normochromic normocytic anaemia when taking Omeprazole*:
Age of people who have Normochromic normocytic anaemia when taking Omeprazole *:
Common drugs people take besides Omeprazole *:
Common side effects people have besides Normochromic normocytic anaemia *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Omeprazole and have Normochromic normocytic anaemia?Check whether Normochromic normocytic anaemia is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Normochromic normocytic anaemia and when was it recovered:
Expand to all the drugs that have ingredients of omeprazole:
Alternative drugs to, pros and cons of Omeprazole:
- Omeprazole (359,875 reports)
Common Omeprazole side effects:
Browse all side effects of Omeprazole:a b c d e f g h i j k l m n o p q r s t u v w x y z
Normochromic normocytic anaemia treatments and more:
- Normochromic normocytic anaemia (4,034 reports)
COVID vaccines that are related to Normochromic normocytic anaemia:
- Normochromic normocytic anaemia in Moderna COVID Vaccine
- Normochromic normocytic anaemia in Pfizer BioNTech Covid Vaccine
- Normochromic normocytic anaemia in Johnson and Johnson Covid Vaccine
Common drugs associated with Normochromic normocytic anaemia:
All the drugs that are associated with Normochromic normocytic anaemia:
- Normochromic normocytic anaemia (1,068 drugs)
Common conditions associated with Normochromic normocytic anaemia:
All the conditions that are associated with Normochromic normocytic anaemia:
- Normochromic normocytic anaemia (604 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on omeprazole (the active ingredients of Omeprazole) and Omeprazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Solu-Cortef and Pulmonary Mass - a second ago
- Glucophage and Renal Osteodystrophy - 2 seconds ago
- Gilenya and Oropharyngeal Discomfort - 2 seconds ago
- Dexamethasone and Malabsorption - 4 seconds ago
- Fish Oil and Neuralgia - 5 seconds ago
- Carafate and Pelvic Venous Thrombosis - 6 seconds ago
- Effexor and Neuralgia - 8 seconds ago
- Baclofen and Asmanex Twisthaler drug interaction - 13 seconds ago
- Prevacid 24 Hr and Levothyroxine Sodium drug interaction - 14 seconds ago
- Methotrexate and Mononeuritis - 17 seconds ago